日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants

在健康受试者中,一次皮下注射2毫升Mirikizumab与两次皮下注射1毫升Mirikizumab具有生物等效性。

Otani, Yuki; Payne, Christopher D; Loftus, Edward V Jr; D'Haens, Geert; Ben Horin, Shomron; Upadhya K, Abhishek; Todd, Kristin; Pellanda, Paola; Shi, Galen; Zhang, Xin

Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study

mirikizumab 对克罗恩病患者报告结局和生活质量的影响:来自 SERENITY II 期研究的结果

Jairath, Vipul; Hunter Gibble, Theresa; Peyrin-Biroulet, Laurent; Sands, Bruce E; Hirai, Fumihito; Hibi, Toshifumi; Loftus, Edward V Jr; Cross, Raymond K; Protic, Marijana; Chan, Lai Shan; Morris, Nathan; Traxler, Kristina; Rubin, David T

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

口服万古霉素是治疗成人炎症性肠病和原发性硬化性胆管炎的有效疗法。

Urquhart, Siri A; Ramesh, Prajith Raj; Kane, Sunanda V; Raffals, Laura E; Loftus, Edward V Jr; Bruining, David H; Stephens, Michael C; Eaton, John E; Lazaridis, Konstantinos N; Hashash, Jana G; Ha, Christina Y; Harmsen, William S; Coelho-Prabhu, Nayantara

Global evolution of inflammatory bowel disease across epidemiologic stages

炎症性肠病在全球流行病学阶段的演变

Hracs, Lindsay; Windsor, Joseph W; Gorospe, Julia; Cummings, Michael; Coward, Stephanie; Buie, Michael J; Quan, Joshua; Goddard, Quinn; Caplan, Léa; Markovinović, Ante; Williamson, Tyler; Abbey, Yvonne; Abdullah, Murdani; Abreu, Maria T; Ahuja, Vineet; Raja Ali, Raja Affendi; Altuwaijri, Mansour; Balderramo, Domingo; Banerjee, Rupa; Benchimol, Eric I; Bernstein, Charles N; Brunet-Mas, Eduard; Burisch, Johan; Chong, Vui Heng; Dotan, Iris; Dutta, Usha; El Ouali, Sara; Forbes, Angela; Forss, Anders; Gearry, Richard; Dao, Viet Hang; Hartono, Juanda Leo; Hilmi, Ida; Hodges, Phoebe; Jones, Gareth-Rhys; Juliao-Baños, Fabián; Kaibullayeva, Jamilya; Kelly, Paul; Kobayashi, Taku; Kotze, Paulo Gustavo; Lakatos, Peter L; Lees, Charlie W; Limsrivilai, Julajak; Lo, Bobby; Loftus, Edward V Jr; Ludvigsson, Jonas F; Mak, Joyce W Y; Miao, YingLei; Ng, Ka Kei; Okabayashi, Shinji; Olén, Ola; Panaccione, Remo; Paudel, Mukesh Sharma; Quaresma, Abel Botelho; Rubin, David T; Simadibrata, Marcellus; Sun, Yang; Suzuki, Hidekazu; Toro, Martin; Turner, Dan; Iade, Beatriz; Wei, Shu Chen; Yamamoto-Furusho, Jesus K; Yang, Suk-Kyun; Ng, Siew C; Kaplan, Gilaad G

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis

利沙珠单抗在治疗中重度活动性溃疡性结肠炎患者中的疗效和安全性:减少皮质类固醇用量的作用

Reinisch, Walter; Loftus, Edward V Jr; Schreiber, Stefan; Rubin, David T; Louis, Edouard; Hecht, Patrick M; Barrachina, Elena Marced; Kalabic, Jasmina; Vladea, Ramona; Sharma, Dolly; Duan, Weijiang Rachel; Zhang, Yafei; Panaccione, Remo

Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study

乌帕替尼维持治疗中重度活动性克罗恩病患者的疗效和安全性:U-ENDURE长期扩展研究的2年结果

Loftus, Edward V Jr; D'Haens, Geert; Louis, Edouard; Regueiro, Miguel; Jairath, Vipul; Magro, Fernando; Nakase, Hiroshi; Dubcenco, Elena; Lacerda, Ana Paula; Ford, Sharanya; Feng, Tian; Duncan, Benjamin; Fish, Irina; Cunneen, Colla; Anyanwu, Samuel I; Aponte, Fernando; Griffith, Jenny; Blumenstein, Irina

Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis

Deucravacitinib治疗炎症性肠病患者:3项随机II期研究(克罗恩病和溃疡性结肠炎)的12周疗效和安全性结果

D'Haens, Geert; Danese, Silvio; Panaccione, Remo; Rubin, David T; Peyrin-Biroulet, Laurent; Matsuoka, Katsuyoshi; Loftus, Edward V Jr; Kobayashi, Taku; Elsharkawi, Walid; Miceli, Rosa; Ahmed, Samia; Luo, Yi; Napoli, Andrew; Vaile, John; Dornic, Quentin; Patel, Aditya; Schreiber, Stefan

A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn's disease

一项关于risankizumab治疗克罗恩病真实世界疗效和安全性的多中心研究

Johnson, Amanda M; Askar, Manar; Belani, Seema; Khan, Abdul; Xu, Anthony A; Kassmeyer, Blake; Said, Hyder; Santiago-Castro, Michael; Devi, Jalpa; Huang, Katherine; Jaiprada, Fnu; Seth, Nickhil; Dulaney, David; Loftus, Edward V Jr; Fenster, Marc; Patel, Anish; Bishu, Shrinivas; Ungaro, Ryan C; Shukla, Richa; Yarur, Andres J; Deepak, Parakkal

Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial

既往生物制剂暴露对奥扎尼莫德在3期True North临床试验中的疗效和安全性的影响

Sands, Bruce E; Rubin, David T; Loftus, Edward V Jr; Wolf, Douglas C; Panaccione, Remo; Colombel, Jean-Frederic; Dignass, Axel; Regueiro, Miguel; Vermeire, Severine; Afzali, Anita; Lawlor, Garrett; Ahmad, Harris A; Wu, Hsiuanlin; Osterman, Mark T; Jain, Anjali; D'Haens, Geert

Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program

评估年龄对依曲莫德治疗溃疡性结肠炎患者的安全性和有效性的影响:ELEVATE UC 临床项目数据的后分析

Lichtenstein, Gary R; Allegretti, Jessica R; Loftus, Edward V Jr; Irving, Peter M; Banerjee, Rupa; Charabaty, Aline; Kuehbacher, Tanja; Bananis, Eustratios; Woolcott, John C; Dalam, Alexis B; Lazin, Krisztina; Keating, Michael; McDonnell, Aoibhinn; Danese, Silvio